Asymmetrical distribution of brain interleukin-6 depends on lateralization in mice

NeuroImmunoModulation

Volumn 12, Issue 3, 2005, Pages 189-194

  Shen, Yan Qin ^a,b   Hébert, Guillaume ^b   Moze, Elisabeth ^b   Li, Kang Sheng ^a   Neveu, Pierre J ^b  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b INSTITUT FRANÇOIS MAGENDIE   (France)

Author keywords

Brain; Immunomodulation; Interleukin 6; Lateralization

Indexed keywords

INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMISPHERE; HIPPOCAMPUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNE RESPONSE; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN CHEMISTRY; CEREBRAL CORTEX; ENZYME-LINKED IMMUNOSORBENT ASSAY; FORELIMB; FUNCTIONAL LATERALITY; HIPPOCAMPUS; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; NEUROIMMUNOMODULATION;

EID: 20944434735     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000084852     Document Type: Article

References (59)

1. Bisazza A, Rogers LJ, Vallortigara G: The origins of cerebral asymmetry: A review of evidence of behavioural and brain lateralization in fishes, reptiles and amphibians. Neurosci Biobehav Rev 1998;22:411-426.
2. Gerendai I, Halasz B: Asymmetry of the neuroendocrine system. News Physiol Sci 2001;16:92-95.
3. Neveu PJ: Cerebral lateralization and the immune system. Int Rev Neurobiol 2002;52:303-323.
4. Betancur C, Neveu PJ, Vitiello S, Le Moal M: Natural killer cell activity is associated with brain asymmetry in male mice. Brain Behav Immun 1991;5:162-169.
5. Fride E, Collins RL, Skolnick P, Arora PK: Strain-dependent association between immune function and paw preference in mice. Brain Res 1990;522:246-250.
6. Neveu PJ, Betancur C, Barneoud P, Vitiello S, Le Moal M: Functional brain asymmetry and lymphocyte proliferation in female mice: Effects of right and left cortical ablation. Brain Res 1991;550:125-128.
7. Gao MX, Li K, Dong J, Liege S, Jiang B, Neveu PJ: Strain-dependent association between lateralization and lipopolysaccharide-induced IL-1β and IL-6 production in mice. Neuroimmunomodulation 2000;8:78-82.
8. Zuo YC, Li YF, Mei L, Fan SG, Ding GF: Brain interleukin-1 is involved in generation of the serum suppressive factor induced by restraint stress in mice. Neuroimmunomodulation 1995;2:82-87.
9. Sullivan GM, Canfield SM, Lederman S, Xiao E, Ferin M, Wardlaw SL: Intracerebroventricular injection of interleukin-1 suppresses peripheral lymphocyte function in the primate. Neuroimmunomodulation 1997;4:12-18.
10. Li S, Goorha S, Ballou LR, Blatteis CM: Intracerebroventricular interleukin-6, macrophage inflammatory protein-1 beta and IL-18: Pyrogenic and PGE(2)-mediated? Brain Res 2003;992:76-84.
11. Sakata Y, Morimoto A, Long NC, Murakami N: Fever and acute-phase response induced in rabbits by intravenous and intracerebroventricular injection of interleukin-6. Cytokine 1991;3:199-203.
12. Chesnokova V, Melmed S: Minireview: Neuroimmuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 2002;143:1571-1574.
13. Mulla A, Buckingham JC: Regulation of the hypothalamo-pituitary-adrenal axis by cytokines. Baillieres Best Pract Res Clin Endocrinol Metab 1999;13:503-521.
14. Mastorakos G, Chrousos GP, Weber JS: Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993;77:1690-1694.
15. Torpy DJ, Papanicolaou DA, Lotsikas AJ, Wilder RL, Chrousos GP, Pillemer SR: Responses of the sympathetic nervous system and the hypothalamic-pituitary- adrenal axis to interleukin-6: A pilot study in fibromyalgia. Arthritis Rheum 2000;43:872-880.
16. Martins JM, Alves J, Trinca A, Grima B, do Vale S, Vasconcelos T, Riso N, Riscado V, da Costa JC: Personality, brain asymmetry, and neuroendocrine reactivity in two immune-mediated disorders: A preliminary report. Brain Behav Immun 2002;16:383-397.
17. Delrue C, Deleplanque B, Rouge-Pont F, Vitiello S, Neveu PJ: Brain monoaminergic, neuroendocrine, and immune responses to an immune challenge in relation to brain and behavioral lateralization. Brain Behav Immun 1994;8:137-152.
18. Neveu PJ, Moya S: In the mouse, the corticoid stress response depends on lateralization. Brain Res 1997;749:344-346.
19. Fu QL, Shen YQ, Gao MX, Dong J, Neveu PJ, Li KS: Brain interleukin asymmetries and paw preference in mice. Neuroscience 2003;116:639-647.
20. Schobitz B, Sutanto W, Carey MP, Holsboer F, de Kloet ER: Endotoxin and interleukin 1 decrease the affinity of hippocampal mineralocorticoid (type I) receptor in parallel to activation of the hypothalamic-pituitary-adrenal axis. Neuroendocrinology 1994;60:124-133.
21. Bratt AM, Kelley SP, Knowles JP, Barrett J, Davis K, Davis M, Mittleman G: Long term modulation of the HPA axis by the hippocampus. Behavioral, biochemical and immunological endpoints in rats exposed to chronic mild stress. Psychoneuroendocrinology 2001;26:121-145.
22. Verkhratsky NS: Limbic control of endocrine glands in aged rats. Exp Gerontol 1995;30:415-421.
23. Collins RL: On the inheritance of direction and degree of asymmetry; in Glick SD (ed): Cerebral Lateralization in Non Human Species. New York, Academic Press, 1985, pp 41-71.
24. Neveu PJ, Barneoud P, Vitiello S, Betancur C, Le Moal M: Brain modulation of the immune system: Association between lymphocyte responsiveness and paw preference in mice. Brain Res 1988;457:392-394.
25. Signore P, Nosten-Bertrand M, Chaoui M, Roubertoux PL, Marchaland C, Perez-Diaz F: An assessment of handedness in mice. Physiol Behav 1991;49:701-704.
26. Cabib S, D'Amato FR, Neveu PJ, Deleplanque B, Le Moal M, Puglisi-Allegra S: Paw preference and brain dopamine asymmetries. Neuroscience 1995;64:427-432.
27. Bluthe RM, Michaud B, Poli V, Dantzer R: Role of IL-6 in cytokine-induced sickness behavior: A study with IL-6 deficient mice. Physiol Behav 2000;70:367-373.
28. Dantzer R, Bluthe RM, Laye S, Bret-Dibat JL, Parnet P, Kelley KW: Cytokines and sickness behavior. Ann NY Acad Sci 1998;840:586-590.
29. Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T: Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: A study on IL-6-deficient mice. J Exp Med 1996;183:311-316.
30. Leon LR: Invited review: Cytokine regulation of fever: Studies using gene knockout mice. J Appl Physiol 2002;92:2648-2655.
31. Turnbull AV, Rivier CL: Regulation of the hypothalamic-pituitary-adrenal axis by cytokines: Actions and mechanisms of action. Physiol Rev 1999;79:1-71.
32. O'Connor KA, Johnson JD, Hansen MK, Wieseler Frank JL, Maksimova E, Watkins LR, Maier SF: Peripheral and central proinflammatory cytokine response to a severe acute stressor. Brain Res 2003;991:123-132.
33. Vitkovic L, Bockaert J, Jacque C: 'Inflammatory' cytokines: Neuromodulators in normal brain? J Neurochem 2000;74:457-471.
34. Li QS, Yang GZ: Immunoregulatory effect of neocortex in mice. Immunol Invest 1987;16:87-96.
35. Renoux G, Biziere K, Renoux M, Guillaumin JM, Degenne D: A balanced brain asymmetry modulates T cell-mediated events. J Neuroimmunol 1983;5:227-238.
36. Qiu Y, Peng Y, Wang J: Immunoregulatory role of neurotransmitters. Adv Neuroimmunol 1996;6:223-231.
37. Reul JM, van den Bosch FR, de Kloet ER: Relative occupation of type-I and type-II corticosteroid receptors in rat brain following stress and dexamethasone treatment: Functional implications. J Endocrinol 1987;115:459-467.
38. Matthews SG: Early programming of the hypothalamo-pituitary-adrenal axis. Trends Endocrinol Metab 2002;13:373-380.
39. Chrousos GP: Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci 1998;851:311-335.
40. Nilsson C, Larsson BM, Jennische E, Eriksson E, Bjomtorp P, York DA, Holmang A: Maternal endotoxemia results in obesity and insulin resistance in adult male offspring. Endocrinology 2001;142:2622-2630.
41. Dahlgren J, Nilsson C, Jennische E, Ho HP, Eriksson E, Niklasson A, Bjorntorp P, Albertsson Wikland K, Holmang A: Prenatal cytokine exposure results in obesity and gender-specific programming. Am J Physiol Endocrinol Metab 2001;281:E326-E334.
42. Samuelsson AM, Ohm I, Dahlgren J, Eriksson E, Angelin B, Folkow B, Holmang A: Prenatal exposure to interleukin-6 results in hypertension and increased hypothalamic-pituitary-adrenal axis activity in adult rats. Endocrinology 2004;145:4897-4911.
43. Lenczowski MJ, Bluthe RM, Roth J, Rees GS, Rushforth DA, van Dam AM, Tilders FJ, Dantzer R, Rothwell NJ, Luheshi GN: Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats. Am J Physiol 1999;276:R652-R658.
44. Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA: Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med 1997;185:1185-1192.
45. Tilders FJ, DeRijk RH, Van Dam AM, Vincent VA, Schotanus K, Persoons JH: Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: Routes and intermediate signals. Psychoneuroendocrinology 1994;19:209-232.
46. Neveu PJ, Liege S, Sarrieau A: Asymmetrical distribution of hippocampal mineralocorticoid receptors depends on lateralization in mice. Neuroimmunomodulation 1998;5:16-21.
47. Dong J, Mrabet O, Moze E, Li K, Neveu PJ: Lateralization and catecholaminergic neuroimmunomodulation: Prazosin, an α1/α2- adrenergic receptor antagonist, suppresses interleukin-1 and increases interleukin-10 production induced by lipopolysaccharides. Neuroimmunomodulation 2002;10:163-168.
48. Hachinski VC, Oppenheimer SM, Wilson JX, Guiraudon C, Cechetto DF: Asymmetry of sympathetic consequences of experimental stroke. Arch Neurol 1992;49:697-702.
49. Wittling W, Block A, Schweiger E, Genzel S: Hemisphere asymmetry in sympathetic control of the human myocardium. Brain Cogn 1998;38:17-35.
50. Marz P, Cheng JG, Gadient RA, Patterson PH, Stoyan T, Otten U, Rose-John S: Sympathetic neurons can produce and respond to interleukin 6. Proc Natl Acad Sci USA 1998;95:3251-3256.
51. Kelles A, Janssens J, Tack J: IL-1β and IL-6 excite neurones and suppress cholinergic neurotransmission in the myenteric plexus of the guinea pig. Neurogastroenterol Motil 2000;12:531-538.
52. Xia Y, Hu HZ, Liu S, Ren J, Zafirov DH, Wood JD: IL-1β and IL-6 excite neurons and suppress nicotinic and noradrenergic neurotransmission in guinea pig enteric nervous system. J Clin Invest 1999;103:1309-1316.
53. Papassotiropoulos A, Hock C, Nitsch RM: Genetics of interleukin 6: Implications for Alzheimer's disease. Neurobiol Aging 2001;22:863-871.
54. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H, Minami M, Nagatsu T: Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 1994;180:147-150.
55. Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T: Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease. Neurosci Lett 1996;211:13-16.
56. Gadient RA, Otten UH: Interleukin-6 (IL-6) - A molecule with both beneficial and destructive potentials. Prog Neurobiol 1997;52:379-390.
57. Bolin LM, Strycharska-Orczyk I, Murray R, Langston JW, Di Monte D: Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice. J Neurochem 2002;83:167-175.
58. Parish CL, Finkelstein DI, Tripanichkul W, Satoskar AR, Drago J, Horne MK: The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J Neurosci 2002;22:8034-8041.
59. Shen YQ, Hebert G, Lin LY, Luo YL, Moze E, Li KS, Neveu PJ: Interleukin-1β and interleukin-6 levels in striatum and other brain structures after MPTP treatment: Influence of behavioral lateralization. J Neuroimmunol 2005;158:14-25.